IMS Market Research Consulting (Shanghai) Co., Ltd. a company of IMS Health (NYSE: RX), is the world's leading provider of business intelligence and strategic consulting services for the pharmaceutical and healthcare industries. With over 50 years' experience in the industry, IMS Health operates in more than 100 countries, integral to customer day-to-day operations by providing strategic insights about the pharmaceutical marketplace. That makes IMS the global gold standard in pharmaceutical information. The pharmaceutical companies listed in Fortune 500 are almost all included in the IMS global clients.

艾美仕市场调研咨询（上海）有限公司是全球领先的为医药健康行业提供专业信息和战略咨询服务的公司-IMS HEALTH（纽约证券市场股票代码：RX）在中国地区设立的公司, IMS HEALTH公司已有50年的历史，凭藉着在世界上100个国家和地区发展业务的丰富行业经验, IMS通过提供与医药行业客户日常运营密切相关的专业战略分析和咨询服务，成为全球医药行业咨询服务的"黄金标准"。全球500强中的制药企业几乎都是IMS全球的客户。

www.imshealth.com